10-Q: Legato Merger Corp. IV Q3 2026 Financial Update

Sentiment:

Quarterly Report


Legato Merger Corp. IV reports net income of $1.79M for Q3 2026, driven by investment income, with ongoing focus on business combination.

Capital raiseThe company consummated an Initial Public Offering (IPO) of 23,000,000 units at $10.00 per unit, generating gross proceeds of $230,000,000.Simultaneously, 550,000 Private Units were sold to initial shareholders and underwriters at $10.00 per unit, generating $5,500,000.Proceeds from the IPO and private placement were placed in a trust account.The company may receive Working Capital Loans from insiders or affiliates, which could be converted into units at $10.00 per unit, up to $1,500,000.

Summary

  • Legato Merger Corp. IV filed its quarterly report for the period ending May 31, 2026.
  • The company reported a net income of $1,788,263 for the three months ended May 31, 2026, and $2,441,324 for the nine months ended May 31, 2026.
  • This income was primarily derived from interest income on investments held in the Trust Account and interest income on cash accounts, as the company has not yet commenced operations.
  • Total assets as of May 31, 2026, were $234,915,346, with $232,301,573 held in the Trust Account.
  • Total liabilities were $8,050,000, primarily consisting of deferred underwriting commissions.
  • The company continues to focus on its objective of acquiring a target business or businesses through a business combination.
  • As of May 31, 2026, the company had $2,427,888 in cash and working capital of $2,613,773.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reflects the expected financial status of a SPAC prior to a business combination, with no significant operational developments or performance metrics to evaluate beyond investment income.

Positives

  • Generated a net income of $1,788,263 for the three months ended May 31, 2026, and $2,441,324 for the nine months ended May 31, 2026, primarily from investment income.
  • Maintained a significant balance in the Trust Account ($232,301,573) to support a future business combination.
  • The company has $2,427,888 in cash and $2,613,773 in working capital as of May 31, 2026, indicating sufficient liquidity for current operations.
  • The underwriters' over-allotment option was exercised in full, which is a positive sign for the initial public offering's reception.

Negatives

  • The company has not yet commenced operations and has no operating revenues, relying solely on investment income.
  • Significant deferred underwriting commissions of $8,050,000 are a liability.
  • The company's ability to complete a business combination within the specified timeframe is not guaranteed.
  • Ordinary shares are subject to possible redemption, which could impact shareholder equity if a business combination is not completed.

Risks

  • The company's ability to complete a Business Combination within the required time period (24 or 27 months) is uncertain, which could lead to liquidation.
  • If a Business Combination is not consummated, the proceeds in the Trust Account may be subject to claims of creditors, potentially reducing the per-share redemption price below $10.00.
  • The ongoing geopolitical instability and resulting market disruptions could adversely affect the company's search for a business combination and the target business.
  • The company is subject to market risk related to its investments held in the Trust Account, although these are primarily U.S. government securities with short maturities.
  • There is no assurance that the company will be able to effect a Business Combination successfully.

Future Outlook

The company's primary objective is to complete a business combination. It intends to use substantially all of the funds held in the Trust Account (excluding deferred underwriting commissions) to acquire a target business or businesses and pay related expenses. If securities are used as consideration, remaining proceeds will be used as working capital for the target business. The company may also receive Working Capital Loans from insiders or affiliates to finance transaction costs.

Management Comments

  • The company's management has broad discretion with respect to the specific application of the net proceeds of this Initial Public Offering and the sale of Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
  • The Company intends to apply to have the Units listed on the New York Stock Exchange (NYSE).
  • The Company has selected August 31 as its fiscal year end.
  • Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's unaudited condensed financial statements.
  • Our management evaluated, with the participation of our principal executive officer and principal financial and accounting officer (our Certifying Officers), the effectiveness of our disclosure controls and procedures as of May 31, 2026, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of May 31, 2026, our disclosure controls and procedures were effective.

Industry Context

StockSavvy.ai notes that Legato Merger Corp. IV, as a Special Purpose Acquisition Company (SPAC), is in a phase focused on identifying and executing a business combination. Its financial performance is currently driven by investment income from its trust account, which is typical for SPACs prior to a merger. The key performance indicator remains the successful completion of a business combination within its mandated timeframe.

Comparison to Industry Standards

  • As a SPAC, Legato Merger Corp. IV's financial reporting is standard for its stage of development. Its net income is derived from interest on its trust account, a common practice for SPACs before a business combination.
  • The structure of its units (ordinary share and one-third warrant) and the exercise price of $11.50 for warrants are within typical ranges for SPACs.
  • The company's focus on completing a business combination within 24-27 months aligns with industry norms for SPACs, after which it will either merge or liquidate.

Related Party Transactions

  • Administrative Service Agreement: The company pays $25,000 per month to an entity controlled by Crescendo Advisors II, LLC for office space and administrative services.
  • Executive Compensation: The CEO and CFO each receive $5,000 per month.
  • Notes Payable to Shareholder: Eric Rosenfeld, Chief SPAC Officer, provided loans totaling $94,225, which were repaid on January 26, 2026.
  • Working Capital Loans: Insiders or affiliates may provide loans to finance transaction costs, which may be repaid or converted into units.

Stakeholder Impact

  • Shareholders: Public shareholders have the option to redeem their shares if a business combination is not completed within the specified timeframe. Founder shares and private units have certain restrictions and do not participate in liquidating distributions if a business combination is not consummated.
  • Warrant Holders: Warrants will expire worthless if a business combination is not completed and the trust account is liquidated. They are exercisable after a business combination and subject to redemption under certain conditions.
  • Underwriters (BTIG): Entitled to deferred underwriting commissions of $8,050,000 upon completion of a business combination.
  • Creditors: Proceeds in the Trust Account could be subject to claims of creditors in the event of bankruptcy or winding up.

Next Steps

  • Complete a business combination with a target business or businesses.
  • If a business combination is not completed within 24 months (or 27 months under certain conditions), the company will cease operations, redeem public shares, and liquidate.
  • The company will use its best efforts to file a registration statement for ordinary shares issuable upon exercise of warrants after the closing of a business combination.

Key Dates

DateDescription
2025-09-01Company incorporated in the Cayman Islands.
2025-10-14First loan from Eric Rosenfeld to the Company.
2025-11-30Balance sheet date for the period ending November 30, 2025.
2025-12-03Second loan from Eric Rosenfeld to the Company.
2025-12-18Third loan from Eric Rosenfeld to the Company.
2025-12-22Fourth loan from Eric Rosenfeld to the Company.
2026-01-01Start of period for certain warrant registration rights.
2026-01-22Registration statement for Initial Public Offering declared effective.
2026-01-23Underwriters exercised the over-allotment option in full.
2026-01-26Company consummated the Initial Public Offering and private placement.
2026-02-28Balance sheet date for the period ending February 28, 2026.
2026-03-01Start of period for certain share and warrant calculations.
2026-05-31Quarterly period end date for the condensed interim financial statements.
2026-07-08Date of report signatures.
2026-12-31Maturity date for promissory notes from Eric Rosenfeld (if not repaid earlier).

Keywords

Legato Merger Corp. IV, Form 10-Q, Quarterly Report, Special Purpose Acquisition Company, SPAC, Business Combination, Trust Account, Initial Public Offering, Redeemable Warrants, Ordinary Shares, Financial Statements

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.